InventionMed Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2014	FY 2013
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Cash & Equivalents	-	-	-	0.51	0.25
Short-Term Investments	-	-	-	26.05	7.58
Cash & Short-Term Investments	0.05	0.11	0.01	13.54	4.04
Cash Growth	669.21%	1637.02%	-99.95%	235.22%	-
Accounts Receivable	1.08	0.6	0.76	0.01	0.08
Other Current Assets	2	1.51	0.07	0.05	0.01
Total Current Assets	3.12	2.22	0.31	13.6	4.12
Net Property, Plant & Equipment	27.33	27.54	27.78	0.01	0.02
Other Intangible Assets	0.04	0.06	0.12	0.46	0.04
Long-Term Investments	9.15	9.15	9.15	0.1	0.1
Other Long-Term Assets	-	0	0	0.04	0
Total Assets	39.64	38.96	37.89	14.22	4.29
Accounts Payable	-	-	-	0.86	0.18
Accrued Expenses	-	-	-	0.02	0.01
Short-Term Debt	-	-	-	0.25	0.29
Other Current Liabilities	0	0	0	0.26	0.26
Total Current Liabilities	0.52	0.37	0.38	1.3	0.66
Long-Term Debt	24.77	24.36	21.48	0.38	0
Other Long-Term Liabilities	35.84	35.6	33.49	2.31	1.08
Total Long-Term Liabilities	60.61	59.95	54.98	2.69	1.08
Total Liabilities	39.17	38.74	36.36	3.98	1.74
Common Stock	20.28	20.28	20.28	0.52	0.45
Additional Paid-in Capital	13.84	13.84	13.84	2.8	0.64
Retained Earnings	-33.65	-33.89	-32.59	6.91	1.47
Shareholders' Equity	0.46	0.23	1.52	10.23	2.55
Total Liabilities & Equity	39.64	38.96	37.89	14.22	4.29
Total Debt	24.77	24.36	21.48	0.63	0.29
Net Cash (Debt)	-24.72	-24.25	-21.48	12.91	3.74
Net Cash Growth	-	-	-	244.71%	-
Net Cash Per Share	-1.19	-1.17	-1.03	0.62	0.21
Book Value	0.46	0.23	1.52	10.23	2.55
Book Value Per Share	0.02	0.01	0.07	0.49	0.14
Tangible Book Value	0.42	0.17	1.4	9.77	2.51
Tangible Book Value Per Share	0.02	0.01	0.07	0.47	0.14